Brief Report

A Survey of Off-label and Unlicensed Antibiotic and Respiratory Medications Prescribed for Toddler Patients


Background: Many medications are unlicensed for use in toddlers and many drugs are prescribed as off-label in this age group. Different studies showed high prevalence of prescribing such medications in children. Prescribing off-labeled or unlicensed drugs can cause adverse drug events (ADEs) and harm to the patients. To evaluate the rate of off-label and unlicensed drugs prescribed for toddlers.

 Methods: Out-patient prescriptions within the electronic database from a main governmental health insurance company in Tehran, Iran were evaluated for off-label and unlicensed drugs in a two-month period (November-December 2019).

 Results: 5358 prescriptions for toddlers reached to the insurance database, of these, 461 prescriptions were randomly selected. Three hundred and fifty prescriptions contained antibiotics and/or respiratory medications, from them, 183 (52.3%) had at least one off-labeled or unlicensed medication. 

Conclusion: Our study showed high rates of off-label and/or unlicensed medication use in pediatric population.

1. Safer DJ. Age-Grouped Differences in Adverse Drug Events from Psychotropic Medication. J Child Adolesc Psychopharmacol. 2011;21(4):299-309.
2. Allen HC, Garbe MC, Lees J, et al. Off-Label Medication use in Children, More Common than We Think: A Systematic Review of the Literature. J Okla State Med Assoc. 2018;111(8):776–83.
3. Palčevski G, Skočibušić N, Vlahović-Palčevski V. Unlicensed and off-label drug use in hospitalized children in Croatia: a cross-sectional survey. Eur J Clin Pharmacol. 2012;68(7):1073-7.
4. Kouti L, Aletayeb M, Aletayeb SMH, Hardani AK, Eslami K. Pattern and extent of off-label and unlicensed drug use in neonatal intensive care units in Iran. BMC Pediatr. 2019;19(3).
5. Pratico AD, Longo L, Mansueto S, et al. Off-label use of drugs and adverse drug reactions in pediatric units: a prospective, multicenter study. Current Drug Safety. 2018;13(3):200-7.
6. Shuib W, Wu XY, Xiao F. Extent, reasons and consequences of off-labeled and unlicensed drug prescription in hospitalized children: a narrative review. World Journal of Pediatrics. 2021;17:341–54.
7. Food and Drug Administration. Pediatric Research Equity Act.Available from:
8. Best pharmaceuticals for children act. Available from: [
9. IsabelGarcía-López, Vendrell M-M, Romero I, Noriega I, González J, RicardoMartino-Alba. Off-Label and Unlicensed Drugs in Pediatric Palliative Care: A Prospective Observational Study. J Pain Symptom Manage. 2020;60(5):923-32.
10. Corny J, Bailey B, Lebel D, Bussières JF. Unlicensed and off-label drug use in paediatrics in a mother-child tertiary care hospital. Paediatr Child Health. 2016;21(2):83-7.
11. Lass J, Irs A, Pisarev H, Leinemann T, Lutsar I. Off label use of prescription medicines in children in outpatient setting in Estonia is common. Pharmacoepidemiol Drug Saf. 2011;20(5):474-81.
12. Santos LD, Heineck I. Drug utilization study in pediatric prescriptions of a university hospital in southern brazil: off-label, unlicensed and high-alert medications. Farm Hosp. 2012;36(4):180-6.
13. Mohamad NF, Ali AM, Shah NM. Respiratory drugs prescribed off-label among children in the outpatient clinics of a hospital in Malaysia. Int J Clin Pharm. 2015;37(1):127-32.
IssueVol 10, No 4 (Autumn 2022) QRcode
SectionBrief Report
Antibiotics Toddler Prescription

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
Soochi A, Abrishami R, Nouroozi A, Taleei D. A Survey of Off-label and Unlicensed Antibiotic and Respiratory Medications Prescribed for Toddler Patients. J Pharm Care. 2022;10(4):234-236.